Skip to content

Treatments of Acquired Apraxia of Speech

Treatments of Acquired Apraxia of Speech

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01483807
Acronym
Apraxia
Enrollment
20
Registered
2011-12-01
Start date
2011-08-01
Completion date
2017-12-31
Last updated
2019-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia, Apraxia of Speech, Stroke

Keywords

speech, speech therapy, apraxia of speech

Brief summary

This study was designed to examine the effects of speech therapy on ability to produce speech sounds in persons with acquired apraxia of speech.

Detailed description

This study was designed to investigate the effects of Sound Production Treatment (SPT; a treatment for acquired apraxia of speech) on sound production accuracy in persons with chronic apraxia of speech (AOS). Organization of practice (blocked practice or randomized practice) will be manipulated in an effort to determine the most efficacious application of SPT. A combination of group and single-subject experimental designs wasl be completed with 20 speakers with AOS (2 groups of 10 participants).

Interventions

BEHAVIORALSound Production Treatment - Blocked

Sound Production Treatment is a treatment for acquired apraxia of speech. Combines therapist modeling, simultaneous production, articulatory instruction, feedback and repeated practice. SPT-Blocked entailed practicing all treatment targets blocked by target. SPT-Random entailed practicing all treatment targets in a non predictable, random order.

BEHAVIORALSound Production Treatment - Random

A treatment for acquired apraxia of speech. Combines therapist modeling, simultaneous production, articulatory instruction, feedback and repeated practice. SPT-Random entailed practicing treatment targets in a non predictable order. SPT-Blocked entailed practicing treatment targets blocked by target.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Each participant received each arm of treatment

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Must have acquired apraxia of speech that occurred following a stroke or other brain injury. * Must be at least 6 months post-onset of brain injury. * May have aphasia.

Exclusion criteria

* History of drug or alcohol abuse. * History of mental illness. * Neurological condition other than that which resulted in apraxia of speech.

Design outcomes

Primary

MeasureTime frameDescription
Speech Production: Effect Size for Treated ItemsPre treatment (2-3 week period preceding the start of treatment) vs. 10 weeks post all treatmentChange in accuracy of articulation of trained items as measured from baseline to 10 weeks post treatment using effect size calculations as the indicator of magnitude of change; production of words designated for treatment was measured repeatedly in non treatment probes prior to treatment, throughout all study phases, and at 10 weeks post treatment with percent accuracy calculated for each probe (maximum = 100%, minimum = 0% correct). Effect size calculations involved calculating the difference between post- and pre-treatment probe accuracy percentages with corrections made for variability (standard deviations in performance). The larger the effect size, the greater the change in performance from pre-treatment. Positive effect sizes = increases in accuracy & negative effect sizes = decreases in accuracy.
Speech Production: Percent Change in Treated Itemsbaseline to 10 weeks post treatmentChange in accuracy of articulation of treated items as measured by percent increase in accuracy above the highest baseline measurement; production of words designated for treatment was measured repeatedly in non treatment probes prior to treatment, throughout all study phases, and at 10 weeks post treatment with percent accuracy calculated for each probe (0% to 100% correct). The highest percentage accuracy achieved in pre-treatment probes was subtracted from the percentage accuracy achieved at 10 weeks post-treatment to obtain change in accuracy value - this reflects change from maximum correct performance in baseline (pre-treatment). e.g., if in baseline probes, performance ranged from 10% to 30% accuracy and at post treatment performance was 90% accuracy, the change value would be 60% (90% minus 30%). A greater change value indicates greater change in articulation/production of words. Change could be positive (improved articulation) or negative (poorer articulation).

Secondary

MeasureTime frameDescription
Speech Production: Percent Change in Untrained Itemsbaseline to 10 weeks post treatmentPercent change in articulatory accuracy of untrained items measured by change in percent accuracy over highest baseline value; production of words designated to NOT receive treatment (untrained items) was measured repeatedly in non treatment probes prior to treatment, throughout all study phases, and at 10 weeks post treatment with percent accuracy calculated for each probe (maximum = 100%, minimum = 0% correct). Effect size calculations involved calculating the difference between post- and pre-treatment probe accuracy percentages with corrections made for variability (standard deviations in performance). The larger the effect size, the greater the change in performance from pre-treatment. Positive effect sizes = increases in accuracy & negative effect sizes = decreases in accuracy.
Speech Production of Untrained Items: Effect Sizes for Untrained ItemsBaseline vs. 10 weeks post all treatmentChange in accuracy of articulation of untrained items as measured by effect sizes reflecting magnitude of change. Production of words designated to not receive treatment (i.e., generalization items) was measured repeatedly in non treatment probes prior to treatment, throughout all study phases, and at 10 weeks post treatment with percent accuracy calculated for each probe (0% to 100% correct). Change in accuracy of articulation of untrained items was measured from baseline to 10 weeks post treatment using effect size calculations as the indicator of magnitude of change. Effect size calculations involved calculating the difference between post- and pre-treatment probe accuracy percentages with corrections made for variability (standard deviations in performance). The larger the effect size, the greater the change in performance from pre-treatment.

Countries

United States

Participant flow

Pre-assignment details

Each participant received each treatment arm in this cross-over design. Order of treatment assignment was random.

Participants by arm

ArmCount
All Participants
All participants received Sound Production Treatment (SPT). Half the participants received SPT applied in a blocked fashion (SPT-B) first for 20 sessions. Following a 2 week washout period, those participants then received SPT applied in random fashion (SPT-R) for 20 sessions. The other half of the participants received the treatments in the opposite order.
20
Total20

Baseline characteristics

CharacteristicAll Participants
Accuracy of Articulation20 Participants
Age, Continuous55.5 years
Race/Ethnicity, Customized
Caucasian/non hispanic
20 Participants
Region of Enrollment
United States
20 Participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Speech Production: Effect Size for Treated Items

Change in accuracy of articulation of trained items as measured from baseline to 10 weeks post treatment using effect size calculations as the indicator of magnitude of change; production of words designated for treatment was measured repeatedly in non treatment probes prior to treatment, throughout all study phases, and at 10 weeks post treatment with percent accuracy calculated for each probe (maximum = 100%, minimum = 0% correct). Effect size calculations involved calculating the difference between post- and pre-treatment probe accuracy percentages with corrections made for variability (standard deviations in performance). The larger the effect size, the greater the change in performance from pre-treatment. Positive effect sizes = increases in accuracy & negative effect sizes = decreases in accuracy.

Time frame: Pre treatment (2-3 week period preceding the start of treatment) vs. 10 weeks post all treatment

Population: 20 speakers with chronic apraxia of speech and aphasia; effect sizes were calculated for each speaker for each treatment condition.

ArmMeasureValue (MEAN)
SPT-R: All ParticipantsSpeech Production: Effect Size for Treated Items6.84 effect size
SPT-B: All ParticipantsSpeech Production: Effect Size for Treated Items6.14 effect size
Comparison: Comparison of performance (change in articulation accuracy) with SPT-R versus SPT-B items. Based on the existing literature, it was predicted that the mean effect size associated with SPT-R would be greater than that for SPT-B.p-value: 0.254t-test, 1 sided
Primary

Speech Production: Percent Change in Treated Items

Change in accuracy of articulation of treated items as measured by percent increase in accuracy above the highest baseline measurement; production of words designated for treatment was measured repeatedly in non treatment probes prior to treatment, throughout all study phases, and at 10 weeks post treatment with percent accuracy calculated for each probe (0% to 100% correct). The highest percentage accuracy achieved in pre-treatment probes was subtracted from the percentage accuracy achieved at 10 weeks post-treatment to obtain change in accuracy value - this reflects change from maximum correct performance in baseline (pre-treatment). e.g., if in baseline probes, performance ranged from 10% to 30% accuracy and at post treatment performance was 90% accuracy, the change value would be 60% (90% minus 30%). A greater change value indicates greater change in articulation/production of words. Change could be positive (improved articulation) or negative (poorer articulation).

Time frame: baseline to 10 weeks post treatment

Population: 20 speakers with chronic apraxia of speech and aphasia received both arms of treatment.

ArmMeasureValue (MEAN)
SPT-R: All ParticipantsSpeech Production: Percent Change in Treated Items46 % change
SPT-B: All ParticipantsSpeech Production: Percent Change in Treated Items38 % change
Comparison: On the basis of existing literature. SPT-R was predicted to be associated with greater increase in articulatory accuracy over baseline levels than SPT-B.p-value: 0.043t-test, 1 sided
Secondary

Speech Production of Untrained Items: Effect Sizes for Untrained Items

Change in accuracy of articulation of untrained items as measured by effect sizes reflecting magnitude of change. Production of words designated to not receive treatment (i.e., generalization items) was measured repeatedly in non treatment probes prior to treatment, throughout all study phases, and at 10 weeks post treatment with percent accuracy calculated for each probe (0% to 100% correct). Change in accuracy of articulation of untrained items was measured from baseline to 10 weeks post treatment using effect size calculations as the indicator of magnitude of change. Effect size calculations involved calculating the difference between post- and pre-treatment probe accuracy percentages with corrections made for variability (standard deviations in performance). The larger the effect size, the greater the change in performance from pre-treatment.

Time frame: Baseline vs. 10 weeks post all treatment

Population: 20 speakers with chronic apraxia of speech and aphasia

ArmMeasureValue (MEAN)
SPT-R: All ParticipantsSpeech Production of Untrained Items: Effect Sizes for Untrained Items2.56 effect size
SPT-B: All ParticipantsSpeech Production of Untrained Items: Effect Sizes for Untrained Items2.11 effect size
Comparison: Comparison of effect sizes obtained for untreated SPT-R versus untreated SPT-B items. It was predicted that effect sizes would be greater for SPT-R untreated items.p-value: 0.212t-test, 1 sided
Secondary

Speech Production: Percent Change in Untrained Items

Percent change in articulatory accuracy of untrained items measured by change in percent accuracy over highest baseline value; production of words designated to NOT receive treatment (untrained items) was measured repeatedly in non treatment probes prior to treatment, throughout all study phases, and at 10 weeks post treatment with percent accuracy calculated for each probe (maximum = 100%, minimum = 0% correct). Effect size calculations involved calculating the difference between post- and pre-treatment probe accuracy percentages with corrections made for variability (standard deviations in performance). The larger the effect size, the greater the change in performance from pre-treatment. Positive effect sizes = increases in accuracy & negative effect sizes = decreases in accuracy.

Time frame: baseline to 10 weeks post treatment

Population: 20 participants with chronic apraxia of speech and aphasia

ArmMeasureValue (MEAN)
SPT-R: All ParticipantsSpeech Production: Percent Change in Untrained Items14 % change
SPT-B: All ParticipantsSpeech Production: Percent Change in Untrained Items13 % change
Comparison: Comparison of change in accuracy of articulation of untreated items: SPT-R versus SPT-B items. It was predicted that there would be a greater increase in accuracy for SPT-R items.p-value: 0.396t-test, 1 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026